India first, benchmarked to North America and Europe. Twelve monthly themes, each with its own whitepapers, industry reports, special newsletters and sponsorable webinars.
BioSpectrum India keeps India at the centre of every issue, then adds a Western lens, alternating North America and Europe to match where the month's news is coming from. Partners can plan a full year of visibility around the conversations that matter most to their buyers.
Every issue is built around a single big question for Indian life sciences, timed to the policy, conference and deal calendar our readers already follow.
Twenty-four whitepaper topics, each designed so one technology or service partner can own the argument with editorial credibility.
Each month pairs an India market report with a global report on North America or Europe, so Indian readers see the benchmark and international readers see the India opportunity.
Themed special editions sent to the full BioSpectrum India subscriber base, many timed to the conferences and events that set the month's agenda.
A standing bank of technology webinars, two slotted against each month's theme, built for partners who want qualified leads as well as visibility.
Execution, bioeconomy policy and the biosimilar opportunity.
Vaccines and immunisation, clinical research and India-origin innovation reaching global deal tables.
Diagnostics and genomics, biologics manufacturing and digitisation, cell and gene therapy.
Rare cancer access, the pharma supply chain reset and the 2028 agenda.
Open any month to see the cover story, the India and global lenses, and every partnership opportunity attached to it.
Each 60-minute webinar brings together one sponsor speaker, one independent Indian practitioner and a BioSpectrum India moderator. Any topic can move to fit your launch calendar or be replaced with a custom brief.
Continuous flow reactors, process intensification
ELN, LIMS and cloud R&D data platforms
Fermentation, strain-to-scale-up bioprocessing
Sustainable manufacturing, utilities, recovery systems
Perfusion, cell retention, single-use bioreactors
LC-MS characterisation, multi-attribute methods
IVT mRNA, lipid nanoparticles, microfluidic mixing
Isolators, RABS, cleanroom disinfection
RBQM, EDC, eConsent, central monitoring
RWD platforms, analytics, evidence generation
Generative chemistry, GPU compute, knowledge graphs
Lab automation, robotics, assay miniaturisation
Sequencing platforms, panels, bioinformatics
Portable PCR, cartridge assays, connectivity
Process analytics, modelling, MES integration
CSV and CSA, audit trails, QMS software
Automated cell processing, closed systems
AAV and lentiviral upstream, purification, titre analytics
Bioconjugation, high-potency containment, DAR analytics
Spatial transcriptomics, multiplex IHC
Temperature-controlled packaging, cryo shipping, tracking
Vials, prefilled syringes, CCI testing
LLM-assisted authoring, case processing automation
Validated cloud, zero-trust security, data residency
Two special editions every month, sent to the full BioSpectrum India subscriber base. Each is available for an exclusive presenting partner.
What US dealmakers and investors said about India, filed during the J.P. Morgan Healthcare Conference week.
New plants, expansions and hiring across India's contract research and manufacturing hubs to track in 2027.
A same-week special edition on what Union Budget 2027-28 means for pharma, biotech, diagnostics and research.
Incentives, new biotech parks and approvals from the states competing for life sciences investment.
The biologics losing exclusivity in the US and Europe, and the Indian developers positioned to launch.
Single-use, perfusion and continuous processing updates for biologics manufacturing teams.
Prequalification, capacity and export updates from India's vaccine makers, published for World Immunization Week.
Annex 1 compliance, fill-finish technology and contamination control practice from the plant floor.
New trial approvals, site network expansions and CRO moves, published on International Clinical Trials Day.
Indian and global oncology data to watch ahead of the ASCO Annual Meeting.
A convention special on Indian delegations, partnering meetings and announcements at the BIO International Convention.
India's licensing, partnership and funding round-up for the first half of the year.
Sequencing programmes, precision medicine launches and population genomics updates from India and abroad.
IVD launches, approvals and point-of-care diagnostics news for laboratory and hospital buyers.
Inspection outcomes, warning letters, remediation stories and Revised Schedule M progress.
Automation, digital twins and process analytics in Indian pharma and biologics plants.
CAR-T, gene therapy and RNA therapeutics updates from Indian developers, hospitals and manufacturers.
European advanced therapy regulation, reimbursement and partnering news for Indian developers.
Indian and global oncology highlights from the ESMO Congress, with access implications for India.
Drug pricing, insurance cover and patient programmes shaping access to innovative medicines in India.
Show preview and exhibitor highlights for CPHI and PMEC India, sent to visitors before they walk the floor.
BIOSECURE, EU security-of-supply rules and API sourcing trends affecting Indian suppliers.
The deals, approvals, policies and people that defined Indian life sciences in 2027.
What AI, talent and Western demand mean for Indian life sciences strategy in the year ahead.
Book any format on its own, or combine them into a theme-month or full-year programme. Share your launch calendar and target audience, and we will map the right months for you.
Themes, report titles and webinar slots may be refined as the 2027 policy and industry calendar firms up. Event references are indicative.
MM Activ Sci-Tech Communications Pvt. Ltd., "Ashirwad", 1st Floor, 36/A/2, S. No. 270, Pallod Farms, Baner Road, Pune 411 045, India